Results 111 to 120 of about 51,886 (205)

Myelodysplastic syndrome.

Nihon Naika Gakkai Zasshi, 1985
openaire   +3 more sources

Novel Genomic Biomarkers Improve Post-Hematopoietic Cell Transplantation Relapse Risk Stratification for Patients With Myelodysplastic Syndromes. [PDF]

JCO Precis Oncol
Zhang T, Auer PL, Dong J, Chen Z, Spellman SR, Saber W, Bolon YT.   +6 more
europepmc   +1 more source

Impact of inflammatory cytokine polymorphisms on the progression of myelodysplastic syndromes. [PDF]

Ann Hematol
Gotoh N, Munkh-Erdene T, Hayashi A, Kasamatsu T, Kitamura M, Kojima A, Okawa T, Oda T, Miyauchi E, Sasaki N, Matsumura I, Matsumoto A, Takei H, Kobayashi N, Miyazawa Y, Ogawa Y, Handa H, Saitoh T.   +17 more
europepmc   +1 more source

Evaluating the patterns of use and safety of lenalidomide treatment in myelodysplastic syndromes: a European, observational multi-registry study. [PDF]

Ther Adv Drug Saf
Kim I, Makwana A, Ezenma V, Navarcikova S, Mittal M, Ho Q, Borda H, Kaehler S.   +7 more
europepmc   +1 more source

CD79B in myelodysplastic syndromes and acute myeloid leukemia: an integrative computational and <i>in vitro</i> study. [PDF]

Front Med (Lausanne)
Kong X, Wei Y, Zhang S, Lu X, Luo R, Liang B, Chen Y.   +6 more
europepmc   +1 more source

Luspatercept for patients with lower-risk myelodysplastic syndromes/neoplasms: a systematic review and meta-analysis. [PDF]

Blood Adv
Alhajahjeh A, Woite NL, Rolles B, Stempel JM, Mina A, Mendez L, Kewan T, Podoltsev NA, Stahl M, Grimshaw AA, Zeidan AM, Bewersdorf JP.   +11 more
europepmc   +1 more source

Myelodysplastic syndromes and risk of kidney function decline: findings from a nationwide Japanese cohort study. [PDF]

Clin Kidney J
Mitsuno R, Kaneko H, Suzuki Y, Ko T, Okada A, Nakayama T, Azegami T, Takeda N, Morita H, Fujiu K, Yokoo T, Yasunaga H, Takeda N, Hayashi K.   +13 more
europepmc   +1 more source

Dynamic Mortality Risk Prediction in Myelodysplastic Syndromes Using Longitudinal Clinical Data. [PDF]

JCO Clin Cancer Inform
Bobak J, Spohr P, Richter S, Streuer A, Schulz FI, Strupp C, Gerhards C, Schmitt N, Luft T, Dietrich S, Germing U, Klau GW.   +11 more
europepmc   +1 more source

Somatic mutations in STAG2 are associated with separated megakaryocyte nuclear lobes in myelodysplastic syndromes. [PDF]

Blood Adv
Wong WJ, Zon RL, Gibson CJ, Ho C, Pozdnyakova O, Neuberg D, Battinelli EM, Luskin MR, Tothova Z, Morgan EA, Ebert BL.   +10 more
europepmc   +1 more source

Metabolomic Investigation of Myelodysplastic Syndromes, Multiple Myeloma, and Homozygous β-Thalassemia. [PDF]

Cells
Chatzikalil E, Bistas K, Kymioni V, Diamantopoulos PT, Solomou EE.   +4 more
europepmc   +1 more source